Patient and graft survival after pre-emptive versus non-pre-emptive kidney transplantation: a single-center experience from Turkey.
Transplant Proc
; 45(3): 932-4, 2013 Apr.
Article
em En
| MEDLINE
| ID: mdl-23622591
ABSTRACT
OBJECTIVE:
We sought to report the graft and patients survival of pre-emptive and non-pre-emptive kidney transplantations performed in our center.METHODS:
The 859 subjects showed a mean age of 36.1 years and included 64.6%; males, who received grafts from living (n = 665) or deceased (n = 194) donors between January 2008 and June 2011. We reviewed their medical records retrospectively, to separately pre-emptive versus non-pre-emptive recipients for year transplant outcomes.RESULTS:
Among the 859 patients, 153 (17.8%) underwent pre-emptive and 706 (82.2%), non-pre-emptive kidney transplantations. The rate of living donors was higher in the pre-emptive group (97.4% vs 73%, respectively). The 1-year graft survivals were 99.3% and 95.8% in pre-emptive and non-pre-emptive transplantation groups, respectively (P > .05). There was no significant difference between groups with respect to patient survival at 1 year (P > .05).CONCLUSION:
In conclusion, graft and patient survival rates between pre-emptive and non-pre-emptive kidney transplantation cases were comparable at 1 year. Pre-emptive kidney transplantation, which eliminates hemodialysis costs and complications, should be preferred as the optimal renal replacement therapy for end-stage renal disease patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Taxa de Sobrevida
/
Transplante de Rim
/
Sobrevivência de Enxerto
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article